Clinical Trial Update: Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study

View source ↗

Summary

Clinical trial update indicating completion of the PERSEIDA study, which explored determination of RAS mutation status in liquid biopsies in subjects with RAS w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Amgen | Conditions: RAS Wild Type mCRC | Status: COMPLETED